Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Biosimilar G-CSF Versus Originator G-CSF for Autologous Peripheral Blood Stem Cell Mobilization: A Comparative Analysis of Mobilization and Engraftment

Julie Stakiw, MD FRCPC, Waleed Sabry, MSc, MD PhD, Mohamed Elemary, MD, Mark J. Bosch, MD, Pat Danyluk, Bsc. Pharm, Vibhuti Aggarwal, Bsc, Prosanta Mondal, PhD

Blood (2018) 132 (Supplement 1): 3345.

https://doi.org/10.1182/blood-2018-99-115341

Published: 2018

Journal Articles

The Impact from Frontline CLL Chemo Immunotherapy Regimen Outcomes Based on Patient Tolerability

Jake Towriss, Bsc, Prosanta Mondal, PhD, Waleed Sabry, MSc, MD PhD, Mohamed Elemary, MD, Hadi Alphonse Goubran, MD FACP, FRCP, Mark J. Bosch, MD, Julie Stakiw, MD FRCPC

Blood (2018) 132 (Supplement 1): 5551.

https://doi.org/10.1182/blood-2018-99-119462

Published: 2018

Journal Articles

Second Autologous Stem Cell Transplant As Salvage Therapy For Multiple Myeloma

Mohamed Elemary, MD, PhD., Mohamed Emara, MD, Ankur Sharma, MD, Sabuj Sarker, Waleed Sabry, MSc, MD, Julie Stakiw, MD

Blood (2013) 122 (21): 5529.

https://doi.org/10.1182/blood.V122.21.5529.5529

Published: 2013

Journal Articles

The Saskatchewan Experience for Using FCR in Treatment of CLL – A Comparison of Oral Versus IV Regimens

Richelle Dyck, Kathy Gesy, Waleed Sabry, MSc, MD, Mohamed Elemary, MD, PhD., David P. Sheridan, MD, Uthaman Moodley, MD, FRCPC, Kelsey Brose, MD, Julie Stakiw, MD

Blood (2011) 118 (21): 4613.

https://doi.org/10.1182/blood.V118.21.4613.4613

Published: 2011

Journal Articles

A Randomized Phase III Trial of Thalidomide and Prednisone as Maintenance Therapy Following Autologous Stem Cell Transplantation (ASCT) In Patients with Multiple Myeloma (MM): The NCIC CTG MY.10 Trial

A. Keith Stewart, Suzanne Trudel, MD, MSC, FRCPC, Nizar J Bahlis, MD, Darrell J White, MD, Waleed Sabry, MSc, MD, Andrew Belch, MD, Tony Reiman, MD, Jean Roy, MD, FRCPC, Chaim Shustik, MD, Michael J. Kovacs, MD, FRCPC, Jonathan Sussman, Ralph M. Meyer, MD, Erica L Harnett, M.Sc., Danila Oana, Judy A Chapman, Lois Shepherd, MD

Blood (2010) 116 (21): 39.

https://doi.org/10.1182/blood.V116.21.39.39

Published: 2010

NARROW

Biosimilar G-CSF Versus Originator G-CSF for Autologous Peripheral Blood Stem Cell Mobilization: A Comparative Analysis of Mobilization and Engraftment

The Impact from Frontline CLL Chemo Immunotherapy Regimen Outcomes Based on Patient Tolerability

Second Autologous Stem Cell Transplant As Salvage Therapy For Multiple Myeloma

The Saskatchewan Experience for Using FCR in Treatment of CLL – A Comparison of Oral Versus IV Regimens

A Randomized Phase III Trial of Thalidomide and Prednisone as Maintenance Therapy Following Autologous Stem Cell Transplantation (ASCT) In Patients with Multiple Myeloma (MM): The NCIC CTG MY.10 Trial

Email alerts

ASH Publications

American Society of Hematology

Biosimilar G-CSF Versus Originator G-CSF for Autologous Peripheral Blood Stem Cell Mobilization: A Comparative Analysis of Mobilization and Engraftment

The Impact from Frontline CLL Chemo Immunotherapy Regimen Outcomes Based on Patient Tolerability

Second Autologous Stem Cell Transplant As Salvage Therapy For Multiple Myeloma

The Saskatchewan Experience for Using FCR in Treatment of CLL – A Comparison of Oral Versus IV Regimens

A Randomized Phase III Trial of Thalidomide and Prednisone as Maintenance Therapy Following Autologous Stem Cell Transplantation (ASCT) In Patients with Multiple Myeloma (MM): The NCIC CTG MY.10 Trial

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only